Search Results

240 results for hans

How the Data Center Backlash Changes Where the Money Goes

Data center backlash is delaying projects, but AI demand is shifting capital toward the companies solving the buildout’s bottlenecks.

3 Stocks to Buy for an AI Chip Recovery

Louis Navellier’s ratings are now flagging several key chipmaker names. And I’d like to share them with you today to showcase the kinds of insights…

CoreWeave Beats – Time to Dive Back Into AI Stocks?

CoreWeave’s powerhouse earnings report… a $132.5B backlog and a new funding plan… where Luke’s AI levels stand… Louis’ presentation tomorrow… free stock recommendations from three…

A Slowdown May Be Exactly What the AI Boom Needs

Nvidia Beats – But AI Questions Linger

Nvidia’s earnings aren’t good enough for Wall Street… is a 50-basis-point hike coming?… where Eric Fry is looking outside AI… Luke Lango’s new non-AI picks

Finding 2027’s Best Stocks May Require Letting Go of 2026’s Winners

Market leadership is shifting into 2027, making stock selection more important as investors follow fundamentals into new sectors.

The AI Trade’s $81 Billion Contradiction

Anthropic’s record-setting debut… the contradiction in the AI trade… Nvidia’s bond warning… will new governors slow data centers?… a date Eric Fry is watching

5 AI Stocks That Could Win After Huang’s Nvidia Exit

On the heels of Jensen Huang’s departure from Nvidia, three InvestorPlace experts share where they see risk and opportunity as the fight for AI spending…

Why 20% Earnings Growth Suddenly Isn’t Good Enough

Why are AI stocks falling despite strong earnings? See how shifting expectations are reshaping valuations and creating new opportunities.

NVIDIA’s Blowout Earnings – And the Next Big Shift in AI

In today’s Market 360, let’s put all the gossip aside and take a closer look at NVIDIA’s spectacular earnings report and what it means for…

AI’s 48-Hour Stress Test Starts Now

NVDA earnings are out – what did we learn?… Huang’s comeback push fizzles… what’s changed in Luke’s overall AI picture… Anthropic’s IPO test arrives on…

Three Things to Consider Before Buying the Anthropic IPO

I’ve been investing for 47 years, and I’ve learned that there’s a big difference between an exciting company and a stock that deserves a place…

The Unlikely Stock That Could “Cushion” an AI Selloff

Since peaking in July, the AI trade has broken down. And it’s been a disaster for latecomers to the AI Revolution.  So, where does that…

How Jensen Huang’s Honeypot Scandal Could Broaden the AI Trade

Nvidia’s Jensen Huang scandal could shift AI spending toward AMD, Broadcom, and Marvell. Luke Lango explains the opportunity, and why he’s staying patient.

The Mag 7 Throne Is Wobbling – Here’s the Stock Poised to Profit

Today, I’ll show you the corner of the market that could profit most from the AI buildout: the companies that keep it powered. I’ll also…

One Stock to Buy as Nvidia Loses Its CEO 

Louis Navellier’s system is still recommending several AI names in the wake of the turmoil at Nvidia Corp. (NVDA). And so, I have one more…

5 Growth Stocks for an AI Market in Transition

Luke Lango examines five growth stocks in cybersecurity, software, and health care as AI data center spending faces mounting pressure.

The Four Words That Reveal a Much Bigger Defense Opportunity

My colleague Luke Lango sees a disconnect between market trends and the defense industry, and has identified companies that could benefit as America replenishes its…

AI Crashes. What To Do Now

Nasdaq 100 down 5%+… Luke Lango’s AI game plan… why Louis Navellier is urging calm… Eric Fry and Jonathan Rose: two different paths, one destination

Anthropic’s IPO Is Coming. Where Are the Best Opportunities?

Louis has been investing for 47 years, and he’s learned that there’s a big difference between an exciting company and a stock that deserves a…

An Entire Industry Is About to Change. Again.

You’d rather be invested in new technologies than the ones they’re replacing.

Anthropic IPO: Why the Stakes Go Far Beyond ANT Stock

The Anthropic IPO tests AI financing. We examine the stakes for Broadcom, Google and AMD, plus the risks of buying Anthropic stock.

Insider Buying Signals: 3 Healthcare Stocks to Watch

Insider buying and share buybacks have put Prothena, Rapport Therapeutics and Azenta on the radar. See the catalysts and risks behind each stock.

Why This Bull Market Could Run for Years (Even If the Fed Hikes)

I’ll share our conversation about this rare buying signal, the bullish historical pattern following midterm elections and why we remain optimistic even as the market…

2 – 10 of 240 results